Historial de carrera de Premal Patel
Antiguos cargos conocidos de Premal Patel.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
EFFECTOR THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 25/08/2021 | 01/04/2022 |
LYELL IMMUNOPHARMA, INC. | Director Técnico/Científico/I+D | 01/07/2018 | 01/04/2020 |
JUNO THERAPEUTICS INC | Corporate Officer/Principal | 01/09/2017 | 01/04/2018 |
PFIZER, INC. | Corporate Officer/Principal | 01/08/2015 | 01/08/2017 |
Formación de Premal Patel.
Rutgers State University of New Jersey | Undergraduate Degree |
University of Washington | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 7 |
Operativa
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Sectorial
Health Technology | 5 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
EFFECTOR THERAPEUTICS, INC. | Health Technology |
LYELL IMMUNOPHARMA, INC. | Health Technology |
PFIZER, INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Juno Therapeutics, Inc.
Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA. | Health Technology |
- Bolsa de valores
- Insiders
- Premal Patel
- Experiencia